Last updated 2026-08-29
- Raised $789M Follow-on PO led by Public, Feb 2036
- Raised $2B debt round led by HSBC, May 2025
- Raised $4.4B debt round, Aug 2018
Total raised
$9.1B
Stage
Mature
Founded
—
Headcount
—
HQ
North Wales, United States
Sector
Pharmaceuticals
About
Teva Pharmaceutical Finance Co, LLC is a Delaware-organized limited liability company and an indirect wholly-owned subsidiary of Teva Pharmaceutical Industries Limited, an Israeli multinational pharmaceutical company. It primarily serves as a financing vehicle for its parent company, issuing debt securities to support Teva Pharmaceutical Industries' global operations and strategic initiatives.
Funding history · 7 rounds · $9.1B total
7 events/rounds · $9.1B Total Funding: $789.0M in Public Equity, $8.3B in Debt
Feb 2036
★ Public
Mar 2026
★ iShares Inc
Feb 2026
★ Public
May 2025
★ HSBC★ Mizuho★ Citigroup★ BNP PARIBAS★ J.P. Morgan★ BofA Securities★ IMI-Intesa Sanpaolo★ Goldman Sachs Bank Europe SEMUFGPNC Capital Markets LLC
Aug 2018
Feb 2015
Nov 2011
★ Goldman, Sachs & Co.★ Barclays Capital Inc.★ Morgan Stanley & Co. LLC★ Citigroup Global Markets Inc.
Offices
North Wales, United States · HQ / main office
Q&A
- What is the primary purpose of Teva Pharmaceutical Finance Co, LLC?
- Teva Pharmaceutical Finance Co, LLC is a Delaware-organized limited liability company that serves as a financing vehicle for its parent company, Teva Pharmaceutical Industries Limited, by issuing debt securities to support global operations and strategic initiatives.
- What is the company's relationship with Teva Pharmaceutical Industries Ltd.?
- Teva Pharmaceutical Finance Co, LLC is an indirect wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., an Israeli multinational pharmaceutical company.
- When did Teva Pharmaceutical Finance Co, LLC secure a Debt Financing round for $2 billion?
- In May 2025, Teva Pharmaceutical Finance Co, LLC secured a Debt Financing round of $2,000,000,000. Lead investors included HSBC and Mizuho.
- What was the amount of the Debt Financing round in August 2018?
- In August 2018, Teva Pharmaceutical Finance Co, LLC completed a Debt Financing round totaling $4,400,000,000.
- What was the amount of the Debt Financing round in February 2015?
- In February 2015, Teva Pharmaceutical Finance Co, LLC completed a Debt Financing round totaling $1,000,000,000.
- When did Teva Pharmaceutical Finance Co, LLC raise $875 million in Debt Financing?
- In November 2011, Teva Pharmaceutical Finance Co, LLC raised $875,000,000 in Debt Financing. Lead investors included Goldman, Sachs & Co. and Barclays Capital Inc.
- What was the total amount raised by Teva Pharmaceutical Finance Co, LLC through its funding rounds?
- According to startupim data, Teva Pharmaceutical Finance Co, LLC has raised a total of $10,375,800,000 across its funding rounds.
- What type of financing did Teva Pharmaceutical Finance Co, LLC secure in January 2006?
- In January 2006, Teva Pharmaceutical Finance Co, LLC secured a Convertible Debt round of $500,000,000. Lead investors included Lehman Brothers Inc. and Citigroup Global Markets Inc.
Tags
pharmaceuticalsfinancedebt-issuance
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Teva Pharmaceutical Finance Co, LLC |
|---|